Back

Notification report


Full notification file


General information

Notification Number
B/NL/16/011

Member State to which the notification was sent
Netherlands

Date of acknowledgement from the Member State Competent Authority
02/11/2016

Title of the Project
TEGs – T cells retrovirally engineered to express a defined γδT cell receptor

Proposed period of release:
01/01/2016 to 01/01/2040

Name of the Institute(s) or Company(ies)
Universitair Medisch Centrum Utrecht (UMCU), Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands;


3. Is the same GMO release planned elsewhere in the Community?
Yes:
Austria; Belgium; Germany; Denmark; Spain; Finland; France; United Kingdom; Greece; Ireland; Italy; Luxembourg; Portugal; Sweden; Iceland; Norway;

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
RNA Virus

Identity of the GMO:
Allogeneic or autologous human T cells retrovirally transduced with a replication- deficient derived viral vector (pMP71, isolated from a murine Moloney Murine Leukemia Virus) to express a yδTCR of human origin

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HumanHomoSapiens---

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known